Figure 2. PSGR-derived peptide-specific T cells recognized HLA-A2 positive PSGR-expressing LNCaP prostate cancer cells.

The expression of PSGR mRNA in different cell lines was determined by RT-PCR (A). PSGR derived peptide-specific T cells were tested for cytotoxicity against both PC3 and LNCaP by the LDH assay (B). Data from B are plotted as means ± SD. Results are representative of three independent experiments. *P<0.05, versus control.